Home Stocks BNB Springs Back From 705.00 as Buyers Eye 750.00 – 20…
Stocks

BNB Springs Back From 705.00 as Buyers Eye 750.00 – 20…

Share

BNB cryptocurrency can be expected to rise further toward the next resistance level 750.00 (former support from the start of October).

  • BNB reversed from key support level 705.00
  • Likely to rise to resistance level 750.00

BNB cryptocurrency recently reversed up from the support zone between the key support level 705.00 (which reversed the price twice in September, as can be seen from the daily BNB chart below), lower daily Bollinger Band and the 38.2% Fibonacci correction of the upward impulse from the start of July. The upward reversal from this support zone created the daily Japanese candlesticks reversal pattern Bullish Engulfing, which stopped the earlier minor ABC correction b – that belongs to the short-term correction B from the start of October.

Given the oversold daily Stochastic, clear daily uptrend and the relative strength of BNB against the cautious crypto sentiment seen today, BNB cryptocurrency can be expected to rise further toward the next resistance level 750.00 (former support from the start of October).

The information does not constitute advice or a recommendation on any course of action and does not take into account your personal circumstances, financial situation, or individual needs. We strongly recommend you seek independent professional advice or conduct your own independent research before acting upon any information contained in this article.

Share
Related Articles

Oracle stock rises nearly 2% today: here’s why

Oracle stock ORCL gained 1.92% on Tuesday as the company expanded its...

Palantir stock at $193 after a 4.4% Knox rebound: bull…

Updated 20 October 2026. Palantir (Nasdaq: PLTR) traded at $193.02 in Tuesday’s...

XRP price at $1.30 below the weekly 200 EMA with the 1…

Updated 20 October 2026. XRP traded at $1.30 on Tuesday 20 October,...

Silence Therapeutics stock closed at $19.58, up 125.58% on…

The obvious reading is that Silence Therapeutics has already been taken out...